# KALA BIO, Inc.: Form 8-K, filed Jul 9, 2025

- Company: [KALA BIO, Inc.](/companies/kala.md) (CIK 1479419)
- Form: 8-K
- Filed: 2025-07-09
- Accepted by EDGAR: Jul 9, 2025, 08:08 ET
- Period: 2025-07-09
- Accession: 0001104659-25-066593
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479419/000110465925066593/tm2520099d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479419/000110465925066593/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479419/000110465925066593/tm2520099d1_8k.htm

Filed Jul 9, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-066593. Last ingested by Listed: Nov 3, 2026, 19:22 ET. No prices; not investment advice.